1α,25-Dihydroxyvitamin D3-24-Hydroxylase (CYP24) Hydroxylates the Carbon at the End of the Side Chain (C-26) of the C-24-fluorinated Analog of 1α,25-Dihydroxyvitamin D3

The sequential oxidation and cleavage of the side chain of 1α,25-dihydroxyvitamin D3(1α,25(OH)2D3) initiated by the hydroxylation at C-24 is considered to be the major pathway of this hormone in the target cell metabolism. In this study, we examined renal metabolism of a synthetic analog of 1α,25(OH)2D3, 24,24-difluoro-1α,25-dihydroxyvitamin D3(F2-1α,25(OH)2D3), C-24 of which was designed to resist metabolic hydroxylation. When kidney homogenates prepared from 1α,25(OH)2D3-supplemented rats were incubated with F2-1α,25(OH)2D3, it was mainly converted to a more polar metabolite. We isolated and unequivocally identified the metabolite as 24,24-difluoro-1α,25,26-trihydroxyvitamin D3(F2-1α,25,26(OH)3D3) by ultraviolet absorption spectrometry, frit-fast atom bombardment liquid chromatography/mass spectroscopy analysis, and direct comparison with chemically synthesized F2-1α,25,26(OH)3D3. Metabolism of F2-1α,25(OH)2D3into F2-1α,25,26(OH)3D3 by kidney homogenates was induced by the prior administration of 1α,25(OH)2D3 into rats. The C-24 oxidation of 1α,25(OH)2D3 in renal homogenates was inhibited by F2-1α,25(OH)2D3 in a concentration-dependent manner. Moreover, F2-1α,25,26(OH)3D3 was formed in ROS17/2.8 cells transfected with a plasmid expressing 1α,25(OH)2D3-24-hydroxylase (CYP24) but not in the cells transfected with that expressing vitamin D3-25-hydroxylase (CYP27) or containing inverted CYP27 cDNA. These results show that CYP24 catalyzes not only hydroxylation at C-24 and C-23 of 1α,25(OH)2D3 but also at C-26 of F2-1α,25(OH)2D3, indicating that this enzyme has a broader substrate specificity of the hydroxylation sites than previously considered.